Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Enzastaurin Versus Lomustine in Glioblastoma

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: February 22, 2006
Last updated: November 21, 2016
Last verified: November 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)